Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Why Pfizer's Deal with Protalix Is Bad News for Big Pharma Sales Reps
BNET Pharma
Wednesday, December 2, 2009 - 9:30am
tags:
drug reps, Protalix BioTherapeutics, Pfizer, Ulypso
Gilead set to benefit from HIV guidelines
FT.com
Wednesday, December 2, 2009 - 9:29am
tags:
HIV, Gilead Sciences, Stavudine, Bristol-Myers Squibb
Lilly Wins Zyprexa Case Against Mississippi
Pharmalot
Wednesday, December 2, 2009 - 9:28am
tags:
Mississippi, Zyprexa, Eli Lilly, lawsuits
Santarus shares rise on FDA drug approval
Marketwatch
Wednesday, December 2, 2009 - 9:26am
tags:
FDA, Santarus, Zegerid, OTC, Merck, Schering Plough
Shire’s Replagal Improves Quality of Life for Fabry’s Patients
Bloomberg
Wednesday, December 2, 2009 - 9:25am
tags:
Fabry's disease, Shire, Replagal
Takeda Plans to Enter India Drug Market to Bolster Sales Growth
Bloomberg
Wednesday, December 2, 2009 - 9:25am
tags:
Takeda, India
Pfizer CEO says he supports Senate healthcare bill
Marketwatch
Wednesday, December 2, 2009 - 9:23am
tags:
Pfizer, healthcare reform, healthcare bill, Jeff Kindler, Pharma CEOs
Merck Lawyers Concede Vioxx Fraud In 2001
Pharmalot
Tuesday, December 1, 2009 - 5:58pm
tags:
Merck, fraud, Vioxx, lawsuits, Supreme Court
AIDS: Still a Problem, Still Big Business for Pharma
Minyanville
Tuesday, December 1, 2009 - 5:57pm
tags:
AIDS, HIV, Bristol-Myers Squibb, Gilead Sciences, GSK, Pfizer, Inovio
Better Buy: Pfizer or Teva Pharmaceutical?
Motley Fool
Tuesday, December 1, 2009 - 5:56pm
tags:
Pfizer, Teva Pharmaceuticals
5-Star Stocks Poised to Pop: Abbott Labs
Motley Fool
Tuesday, December 1, 2009 - 10:36am
tags:
Abbott Laboratories
Somaxon Pharmaceuticals: FDA Close to a Decision for Silenor
Seeking Alpha
Tuesday, December 1, 2009 - 10:26am
tags:
Silenor, FDA, Somaxon
MedImmune licenses RSV antibodies in $338M deal
Fierce Biotech
Tuesday, December 1, 2009 - 10:25am
tags:
RSV, antibodies, MedImmune, liscensing, Trellis Biosciences
Analyst Note: Goldman cautious on Abbott, Lilly
Yahoo/AP
Tuesday, December 1, 2009 - 10:23am
tags:
Abbott Laboratories, Eli Lilly
Merck To Supremes: Investors Should Have Sued Us Sooner
WSJ Online
Tuesday, December 1, 2009 - 9:51am
tags:
Merck, Vioxx, lawsuits, Supreme Court
Immunogen's Busy Month, Part I
Seeking Alpha
Tuesday, December 1, 2009 - 9:45am
tags:
Immunogen, GSK, Sanofi, Roche/Genentech
Pharma industry faces rising tax burden, PwC says
Reuters
Tuesday, December 1, 2009 - 9:21am
tags:
pharma industry, taxes
Abbott's TriCor: How a Decades-Old Drug Is Still a Patented Blockbuster
WSJ Online
Tuesday, December 1, 2009 - 9:20am
tags:
TriCor, Abbott Laboratories, cholesterol
Impotence Pill Makers Fined For Price Fixing
Pharmalot
Tuesday, December 1, 2009 - 9:18am
tags:
price fixing, Switzerland, impotence, Cialis, Pfizer, Eli Lilly, Bayer, Viagra, Levitra
Pfizer, Protalix agree deal on taliglucerase
Marketwatch
Tuesday, December 1, 2009 - 9:16am
tags:
partnerships, Protalix BioTherapeutics, Pfizer, taliglucerase, Gaucher disease

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.